Pancuronium Related Published Studies
Well-designed clinical trials related to Pancuronium
Similar preoperative hemodynamic response to pancuronium and rocuronium in high-risk cardiac surgical patients. [2005.12]
Does pancuronium or cisatracurium delay the rate of arousal following remifentanil-based anesthesia? [2005.10]
Interaction between mivacurium and pancuronium: impact of the order of administration. [2005.05]
Myocardial performance index with sevoflurane-pancuronium versus fentanyl-midazolam-pancuronium in infants with a functional single ventricle. [2004.12]
Different F-wave recovery after neuromuscular blockade with pancuronium and mivacurium. [2004.11]
Postanesthesia care unit recovery times and neuromuscular blocking drugs: a prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium. [2004.01]
Recovery of neuromuscular function after cardiac surgery: pancuronium versus rocuronium. [2003.05]
Prospective randomised double-blind comparative study of rocuronium and pancuronium in adult patients scheduled for elective 'fast-track' cardiac surgery involving hypothermic cardiopulmonary bypass. [2003.03]
[Cisatracurium in coronary bypass operations--a comparison with pancuronium. Hemodynamic and neuromuscular effects in patients under chronic beta blocker treatment] [2001.02]
Impact of the initial doses of rocuronium and pancuronium on subsequent maintenance for neuromuscular block. [2001.02]
Effect of pipecuronium and pancuronium on intracranial pressure and cardiovascular parameters in patients with supratentorial tumours. [2000.03]
Postoperative residual paralysis and respiratory status: a comparative study of pancuronium and vecuronium. [2000]
Paralysis in the critically ill: intermittent bolus pancuronium compared with continuous infusion. [1999.12]
Effect of atracurium or pancuronium on the anemic fetus during and directly after intravascular intrauterine transfusion. A double blind randomized study. [1999.10]
Effects of priming with pancuronium or rocuronium on intubation with rocuronium in children. [1999.08]
Respiratory depressant and skeletal muscle relaxant effects of low-dose pancuronium bromide in spontaneously breathing, isoflurane-anesthetized dogs. [1998.09]
[Histamine plasma concentration and cardiovascular effects of non-depolarizing muscle relaxants: comparison of atracurium, vecuronium, pancuronium and pipecuronium in coronary surgical patients at risk] [1998.06]
Potency and hourly maintenance requirement of combinations of mivacurium and pancuronium in adults. [1998.03]
Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. [1997.10]
Residual neuromuscular blockade after cardiac surgery: pancuronium vs rocuronium. [1997.08]
Interactions between mivacurium and pancuronium. [1997.07]
The use of 0.25% lidocaine with fentanyl and pancuronium for intravenous regional anesthesia. [1997.04]
Decreased mivacurium constant infusion requirements with defasciculating doses of pancuronium. [1997.03]
[Drug onset time of atracurium after pancuronium priming in elderly patients] [1997]
Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium? [1996.10]
[Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium] [1996.06]
Effect of isoflurane and sevoflurane on the magnitude and time course of neuromuscular block produced by vecuronium, pancuronium and atracurium. [1996.03]
Effects of enflurane and isoflurane anesthesia on the pharmacokinetics of pancuronium in adult patients. [1996.03]
Mivacurium when preceded by pancuronium becomes a long-acting muscle relaxant. [1996.03]
Haemodynamic effects of high-dose vecuronium compared with pancuronium in beta-blocked patients with coronary artery disease during fentanyl-diazepam-nitrous oxide anaesthesia. [1996.01]
Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia. [1996]
Effects of pipecuronium and pancuronium on cerebrospinal fluid pressure in neurosurgical patients. [1996]
[Clinical research of muscular relaxation induced by alcuronium and pancuronium] [1995.08]
Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium. [1995.08]
Synergism between mivacurium and pancuronium in adults. [1995.08]
Train-of-four recovery after pharmacologic antagonism of pancuronium-, pipecuronium-, and doxacurium-induced neuromuscular block in anaesthetized humans. [1995.04]
Diabetic autonomic neuropathy and the haemodynamic actions of vecuronium and pancuronium during vitrectomy. [1995.04]
Antagonism of pancuronium- and pipecuronium-induced neuromuscular block. [1995.04]
Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents. [1995.03]
Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children. [1994.11]
Pancuronium or vecuronium for treatment of shivering after cardiac surgery. [1994.09]
A comparison of pipecuronium with pancuronium on haemodynamic variables and plasma catecholamines in coronary artery bypass patients. [1994.06]
Neuromuscular blockade of the fetus with pancuronium or pipecuronium for intra-uterine procedures. [1994.04]
Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block. [1994.01]
Circulatory drugs modify the hemodynamic actions of alfentanil combined with vecuronium or pancuronium. [1994]
Accelerated onset and delayed recovery of neuromuscular block induced by mivacurium preceded by pancuronium in children. [1993.05]
Suxamethonium myalgia: an ethnic comparison with and without pancuronium pretreatment. [1993.05]
Hemodynamic and pharmacodynamic comparison of doxacurium and pipecuronium with pancuronium during induction of cardiac anesthesia: does the benefit justify the cost? [1993.03]
Neostigmine and edrophonium antagonism of moderate neuromuscular block induced by pancuronium or tubocurarine. [1993.02]
Pancuronium, vecuronium, and heart rate during anesthesia for aortocoronary bypass operations. [1993]
Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal. [1992.11]
[Plasma histamine levels after the administration of atracurium or pancuronium in patients undergoing general anesthesia] [1992.11]
Effect of morphine and pancuronium on the stress response in ventilated preterm infants. [1992.10]
Rapid-sequence intubation of head trauma patients: prevention of fasciculations with pancuronium versus minidose succinylcholine. [1992.08]
Comparison of meperidine and pancuronium for the treatment of shivering after cardiac surgery. [1992.07]
Alfentanil combined with vecuronium or pancuronium: haemodynamic implications. [1992.07]
Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia. [1992]
Ventilatory compliance after three sufentanil-pancuronium induction sequences. [1991.12]
Dose requirements of vecuronium, pancuronium, and atracurium during orthotopic liver transplantation. [1991.12]
Pretreatment with pancuronium before suxamethonium administration in patients heterozygous for the usual and the atypical plasma cholinesterase gene. [1991.08]
Effects of atracurium and pancuronium on the oculocardiac reflex in children. [1991.07]
Cardio-vascular effects of vecuronium & pancuronium in patients undergoing elective closed mitral valvotomy. [1991.06]
Comparison of the haemodynamic effects of pipecuronium and pancuronium during fentanyl anaesthesia. [1991.04]
The effects of suxamethonium and pancuronium on the haemodynamic response to endotracheal intubation. [1991.03]
Effects of succinylcholine on the pharmacodynamics of pipecuronium and pancuronium. [1991.03]
Priming of pancuronium with magnesium. [1991.02]
Pretreatment with d-tubocurarine, vecuronium, and pancuronium attenuates succinylcholine-induced increases in plasma norepinephrine concentrations in humans. [1991.01]
Cardiovascular effects of doxacurium, pancuronium and vecuronium in anaesthetized patients presenting for coronary artery bypass surgery. [1990.10]
[Hemodynamics and myocardial energy balance in coronary surgery patients during high-dose fentanyl-pancuronium anesthesia and modified neurolept-pancuronium anesthesia] [1990.08]
The influence of pancuronium and vecuronium combined with balanced anaesthesia on haemodynamics and myocardial oxygen balance. [1990.07]
Comparative clinical evaluation of chandonium iodide and pancuronium bromide as muscle relaxant. [1990.04]
Comparison of neuromuscular block in the diaphragm and hand after administration of tubocurarine, pancuronium and alcuronium. [1990.03]
[Sufentanil: the effect on cardiocirculatory parameters and intubation conditions on administration of pancuronium or vecuronium] [1989.12]
Influence of suxamethonium on the action of subsequently administered vecuronium or pancuronium. [1989.03]
The incidence of myocardial ischemia during anesthesia for coronary artery bypass surgery in patients receiving pancuronium or vecuronium. [1989.02]
Atracurium and pancuronium in renal insufficiency. [1989.01]
Pipecuronium and pancuronium: comparison of pharmacokinetics and duration of action. [1988.12]
Influence of beta-blockers on vecuronium/sufentanil or pancuronium/sufentanil combinations for rapid induction and intubation of cardiac surgical patients. [1988.10]
Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade. [1988.08]
Neostigmine and edrophonium as antagonists of atracurium and pancuronium. [1988.08]
Administration of vecuronium, atracurium and pancuronium in divided doses: effect on onset and duration of action. [1988.07]
Reversal of pancuronium. Neuromuscular and cardiovascular effects of a mixture of neostigmine and glycopyrronium. [1988.06]
The induction phase of neuromuscular block after suxamethonium and pancuronium: analysis of the time constant of single-twitch decay (tau T1). [1988.05]
Maintenance of constant 95% neuromuscular blockade by adjustable infusion rates of pancuronium and atracurium. [1988.04]
Thiopentone reduces the haemodynamic response to induction of high-dose fentanyl-pancuronium anaesthesia in coronary artery surgical patients. [1988.04]
Residual curarisation: a comparative study of atracurium and pancuronium. [1988.02]
Comparison of recovery after neuromuscular blockade by atracurium or pancuronium. [1988.01]
Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine. [1988.01]
Side effects and changes in pulmonary function after fixed dose precurarization with alcuronium, pancuronium or vecuronium. [1987.12]
Neostigmine, pyridostigmine and edrophonium as antagonists of deep pancuronium blockade. [1987.11]
Antagonism of pancuronium and tubocurarine blocks by edrophonium or neostigmine: a comparative study. [1987.11]
Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine. [1987.08]
[Spontaneous development of paralysis induced by equipotent doses of vecuronium, atracurium, fazadinium, pancuronium, gallamine and d-tubocurarine] [1987]
Well-designed clinical trials possibly related to Pancuronium
Treatment of Posttraumatic Stress Disorder in Postwar Kosovar Adolescents Using Mind-Body Skills Groups: A Randomized Controlled Trial. [2009.01.17]
Cyproheptadine for the treatment of functional abdominal pain in childhood: a double-blinded randomized placebo-controlled trial. [2008.12]
Glucose control in sepsis. [2008.12]
Prospective, randomized cross-over trial to assess the ability of a dry-powder inhaler to reverse the local side effects of pressurized metered-dose inhalers. [2008.11]
Description and validation of the pelv-sim: a training model designed to improve gynecologic minimally invasive suturing skills. [2008.11]
The Addition of 4% Oxygen to the CO(2) Pneumoperitoneum Does Not Decrease Dramatically Port Site Metastases. [2008.11]
Predictors of emesis and time to goal intake after pyloromyotomy: analysis from a prospective trial. [2008.11]
Economic evaluation of coronary artery bypass grafting surgery with and without cardiopulmonary bypass: cost-effectiveness and quality-adjusted life years in a randomized controlled trial. [2008.11]
|
